AWM
IONS icon

Activest Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Activest Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79 Buy
+1
New +$75 ﹤0.01% 1266
2026
Q1 		– Sell
-32
Closed -$2.53K – 1282
2025
Q4 		$2.53K Buy
+32
New +$2.41K ﹤0.01% 855
2025
Q1 		– Sell
-1
Closed -$33 – 1118
2024
Q4 		$35 Buy
+1
New +$37 ﹤0.01% 794

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Activest Wealth Management's IONS Position: Q2 2026 in Review

Activest Wealth Management opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 1 share worth $79. The stake represents ﹤0.01% of the portfolio and ranks #1266 among its holdings. This is a return to the name: Activest Wealth Management previously reported a position in IONS as recently as Q4 2025.

Activest Wealth Management first reported a position in IONS in Q4 2024 and has held it in 3 quarters since. The position peaked at $2.53K in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Activest Wealth Management held 1 share of Ionis Pharmaceuticals worth $79 as of Q2 2026.
  • Ionis Pharmaceuticals was a new Activest Wealth Management position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1266 holding.
  • Activest Wealth Management first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Activest Wealth Management's Ionis Pharmaceuticals position peaked at $2.53K in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.